PerkinElmer announces Dexela acquisition

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Dexela Limited, a London, UK-based provider of flat panel Complementary Metal-Oxide-Semiconductor (CMOS) X-ray detection technologies and services.

“Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability - which are major advantages for OEM customers”

The acquisition of Dexela expands PerkinElmer's current medical imaging portfolio in key areas including surgery, dental CT, cardiology, and mammography, as well as non-destructive testing (NDT). With the addition of the CMOS technology to the Company's imaging portfolio, customers will now be able to choose seamlessly between two complementary X-ray detector technologies to optimize their system performance and meet their specific application needs.

Founded in 2005, Dexela develops and commercializes its CMOS technology portfolio, which includes hardware and software offerings for fast, low-dose X-ray imaging. The company's CMOS products offer high spatial resolution, frame rate and reliability, low noise and absence of image lag. The Dexela technology is designed to provide high image quality, whether detecting defects in human tissue or industrial objects and structures, through design-friendly components that can be easily incorporated into an Original Equipment Manufacturer (OEM) instrument or platform.

In addition to its CMOS X-ray detection units, Dexela technologies and services include its Dexela Mammography Workstation, the DexView Image Processing Software, its 3D Reconstruction Engine Software, and Consulting and Implementation Services

"Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability - which are major advantages for OEM customers," said Brian Giambattista, President, Medical Imaging, PerkinElmer. "We look forward to expanding the reach of this promising technology into adjacent markets such as surgery, dental CT, cardiology, mammography and industrial NDT, to detect, monitor and remediate threats to human health or structural integrity."

SOURCE PerkinElmer, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2011, June 13). PerkinElmer announces Dexela acquisition. News-Medical. Retrieved on February 26, 2020 from https://www.news-medical.net/news/20110613/PerkinElmer-announces-Dexela-acquisition.aspx.

  • MLA

    PerkinElmer. "PerkinElmer announces Dexela acquisition". News-Medical. 26 February 2020. <https://www.news-medical.net/news/20110613/PerkinElmer-announces-Dexela-acquisition.aspx>.

  • Chicago

    PerkinElmer. "PerkinElmer announces Dexela acquisition". News-Medical. https://www.news-medical.net/news/20110613/PerkinElmer-announces-Dexela-acquisition.aspx. (accessed February 26, 2020).

  • Harvard

    PerkinElmer. 2011. PerkinElmer announces Dexela acquisition. News-Medical, viewed 26 February 2020, https://www.news-medical.net/news/20110613/PerkinElmer-announces-Dexela-acquisition.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
You might also like... ×
Verinata Health provides follow-up data on Verifi prenatal test